Pfizer Files 8K - Other Events
March 17 2017 - 3:21PM
Dow Jones News
Pfizer Inc. (PFE) filed a Form 8K - Other Events - with the U.S
Securities and Exchange Commission on March 17, 2017.
On March 17, 2017, Pfizer Inc. (the "Company") completed the
previously announced public offering of $1,065,000,000 aggregate
principal amount of 4.20% Notes due 2047 (the "Notes"), pursuant to
the subscription agreement dated February 24, 2017 among the
Company, BNP Paribas, Taipei Branch and Deutsche Bank AG, Taipei
Branch, as managers.
The offering of the Notes was made pursuant to the Company's
shelf registration statement on Form S-3 (Registration No.
333-202430) filed with the Securities and Exchange Commission on
March 2, 2015.
The Notes were issued pursuant to an indenture, dated as of
January 30, 2001, between the Company and The Bank of New York
Mellon (formerly known as The Bank of New York), as successor to
JPMorgan Chase Bank (formerly known as The Chase Manhattan Bank),
as trustee, as supplemented by the eighth supplemental indenture,
dated as of March 17, 2017, among the Company and The Bank of New
York Mellon, as trustee and The Bank of New York Mellon, London
Branch, as paying agent (the "Eighth Supplemental Indenture").
The Eighth Supplemental Indenture is filed herewith as Exhibit
4.2 to this Form 8-K and is incorporated herein by reference.
In addition, in connection with the offering of the Notes, the
Company is filing a legal opinion regarding the validity of the
Notes, filed herewith as Exhibit 5.1 to this Form 8-K and is
incorporated herein by reference.
The full text of this SEC filing can be retrieved at:
http://www.sec.gov/Archives/edgar/data/78003/000119312517087159/d347858d8k.htm
Any exhibits and associated documents for this SEC filing can be
retrieved at:
http://www.sec.gov/Archives/edgar/data/78003/000119312517087159/0001193125-17-087159-index.htm
Public companies must file a Form 8-K, or current report, with
the SEC generally within four days of any event that could
materially affect a company's financial position or the value of
its shares.
(END) Dow Jones Newswires
March 17, 2017 15:06 ET (19:06 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pfizer (NYSE:PFE)
Historical Stock Chart
From Apr 2023 to Apr 2024